Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lou Lange
AddedMar 31, 2024
UpdatedMay 31, 2026
Lou Lange

Lou Lange

Board Member, Rapidscan Pharma Solutions

Crunchbase

Lou Lange's Career

Rapidscan Pharma Solutions
Rapidscan Pharma Solutions

Los Altos, CA, US

Board Member· Board
Revitope Oncology
Revitope Oncology

San Francisco, CA, US

Board Member· Board
Amygdala Neurosciences
Amygdala Neurosciences

Palo Alto, CA, US

Board Member· Board
Maverix Biomics
Maverix Biomics

San Mateo, CA, US

Board Member· Board
Cardiodx
Cardiodx

Redwood City, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lou Lange's Career

Rapidscan Pharma Solutions
Rapidscan Pharma Solutions
Series A$2.4M72010Los Altos, CA, US
Board Member· Board

Leadership at Rapidscan Pharma Solutions

Dan SpiegelmanDan SpiegelmanCo-Founder

Similar to Rapidscan Pharma Solutions

Marval PharmaMarval PharmaSan Diego, CA, USImaging Agentsest. 2007Marval PharmaSan Diego, CA, US · est. 2007

Marval Biosciences develops biomedical imaging agents for acute chest pain diagnosis.

Seed · $7.1M5
CorscansCorscansBoulder, CO, USDiagnostics, Healthcareest. 2020CorscansBoulder, CO, US · est. 2020

Revolutionizing heart health with gold-standard C-IMT scans, for a healthier world.

Seed · $40k6
ThromboVisionThromboVisionHouston, TX, USDiagnostic Solutionsest. 2006ThromboVisionHouston, TX, US · est. 2006

ThromboVision: A biomedical firm offering cost-effective cardiovascular diagnostic solutions for healthier lives.

Series A · $4M3
Rapid DiagnostekRapid DiagnostekHudson, WI, USDiagnostic Testsest. 2012Rapid DiagnostekHudson, WI, US · est. 2012

Rapid Diagnostek: Biosensor-based diagnostic test developer for proteins, bacteria, and viruses.

Series B · $14.2M30
Revitope Oncology
Revitope Oncology
Series A$8.5M322014San Francisco, CA, US
Board Member· Board

Leadership at Revitope Oncology

Mark CobboldMark CobboldBoard Member
David MillarDavid MillarCo-Founder
Carsten ReinhardtCarsten ReinhardtBoard Member
Andrew AllenAndrew AllenCo-Founder
Steve ArkinstallSteve ArkinstallCEO
Andrew R. AllenAndrew R. AllenBoard Member
Amygdala Neurosciences
Amygdala Neurosciences
Seed$8.9M302015Palo Alto, CA, US
Board Member· Board

Leadership at Amygdala Neurosciences

Peter StrumphPeter StrumphCo-Founder
Ivan DiamondIvan DiamondCo-Founder
Brent BlackburnBrent BlackburnCo-Founder & CEO
Adrienne MacMillanAdrienne MacMillanBoard Member

Similar to Amygdala Neurosciences

Embera NeurotherapeuticsEmbera NeurotherapeuticsSudbury, MA, USPharmaceuticalsest. 2005Embera NeurotherapeuticsSudbury, MA, US · est. 2005

Embera NeuroTherapeutics: Pioneering targeted addiction treatments in the US pharmaceutical sector.

Series A · $28.4M11
AdrxAdrxThousand Oaks, CA, USDrug Discoveryest. 2013AdrxThousand Oaks, CA, US · est. 2013

ADRx, Inc.: A California-based biopharmaceutical firm innovating novel drugs for amyloid diseases.

Series A · $24.3M9
NeurotypeNeurotypeMinneapolis, MN, USMedical Deviceest. 2019NeurotypeMinneapolis, MN, US · est. 2019

NeuromarkR: A brain-focused medical device combating drug addiction via tailored psychotherapy and mindfulness strategies.

Seed · $1.2M5
Alto NeuroscienceAlto NeuroscienceLos Altos, CA, USBiopharmaceuticalsest. 2019Alto NeuroscienceLos Altos, CA, US · est. 2019

Alto Neuroscience, a US-based clinical-stage biopharma, develops precision medicines using AI-driven biomarkers.

Series C · $239.3M72
Maverix Biomics
Maverix Biomics
Series A$14M242012San Mateo, CA, US
Board Member· Board

Leadership at Maverix Biomics

Dave MandelkernDave MandelkernFounder
Andrew T. YangAndrew T. YangBoard Member

Similar to Maverix Biomics

BioDatomicsBioDatomicsBethesda, MD, USSoftwareest. 2010BioDatomicsBethesda, MD, US · est. 2010

BioDatomics: Advanced software tool for omics research, simplifying complex bio-research since 2010.

Seed · $1.5M30
BioTuringBioTuringSan Diego, CA, USBioinformatics, Data Analysisest. 2016BioTuringSan Diego, CA, US · est. 2016

BioTuring: A San Diego-based bioinformatics firm transforming NGS data analysis since 2016.

Pre-Seed · $1M20
BioinformaticsBioinformaticsArlington, VA, USMarket Research, Softwareest. 1994BioinformaticsArlington, VA, US · est. 1994

Virginia-based software company offering bioinformatics and market research for life science industries.

Series B · $26.2M29
DnanexusDnanexusMountain View, CA, USData Analysis, Data Managementest. 2009DnanexusMountain View, CA, US · est. 2009

American firm DNAnexus offers cloud-based DNA sequence data analysis and management.

Series H · $472.6M292
Cardiodx
Cardiodx
Series B$337.3M1462004Redwood City, CA, US
Board Member· Board

Leadership at Cardiodx

David LevisonDavid LevisonFounder
Brook ByersBrook ByersBoard Member
Ajit SinghAjit SinghBoard Member
Patrick EnrightPatrick EnrightBoard Member
David L LevisonDavid L LevisonBoard Member

Lou Lange's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Lou Lange

George BickerstaffGeorge BickerstaffBoard Member · InnovivaNiall CairnsNiall CairnsBoard Member · CardieXJohn BalenJohn BalenBoard Member · Commerce OneNever WorkedHereNever WorkedHereChairman at CardiacSenseDan LaneDan LaneCo-Founder · Bababoo